{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T21:40:31Z","timestamp":1788212431079,"version":"build-2803163510"},"reference-count":92,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001001","name":"Dementia Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.chest.2022.04.151","type":"journal-article","created":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T02:10:51Z","timestamp":1651889451000},"page":"452-465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Cannabinoids, Insomnia, and Other Sleep Disorders"],"prefix":"10.1016","volume":"162","author":[{"given":"Isobel","family":"Lavender","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9307-7159","authenticated-orcid":false,"given":"Iain S.","family":"McGregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Suraev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald R.","family":"Grunstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6543-4016","authenticated-orcid":false,"given":"Camilla M.","family":"Hoyos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chest.2022.04.151_bib1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.smrv.2018.10.006","article-title":"Insomnia as a predictor of mental disorders: a systematic review and meta-analysis","volume":"43","author":"Hertenstein","year":"2019","journal-title":"Sleep Med Rev"},{"issue":"2","key":"10.1016\/j.chest.2022.04.151_bib2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.chest.2017.01.026","article-title":"Insomnia and risk of cardiovascular disease","volume":"152","author":"Javaheri","year":"2017","journal-title":"Chest"},{"issue":"4 Suppl","key":"10.1016\/j.chest.2022.04.151_bib3","first-page":"S91","article-title":"Economic burden and managed care considerations for the treatment of insomnia","volume":"26","author":"Taddei-Allen","year":"2020","journal-title":"Am J Managed Care"},{"issue":"1","key":"10.1016\/j.chest.2022.04.151_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.sleh.2017.10.006","article-title":"Prevalence and comorbidity of sleep conditions in Australian adults: 2016 Sleep Health Foundation National Survey","volume":"4","author":"Appleton","year":"2018","journal-title":"Sleep Health"},{"issue":"6","key":"10.1016\/j.chest.2022.04.151_bib5","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s11606-018-4390-1","article-title":"Increasing access to and utilization of cognitive behavioral therapy for insomnia (CBT-I): a narrative review","volume":"33","author":"Koffel","year":"2018","journal-title":"J\u00a0Gen Intern Med"},{"issue":"7","key":"10.1016\/j.chest.2022.04.151_bib6","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/arclin\/acx120","article-title":"The residual medium and long-term cognitive effects of benzodiazepine use: an updated meta-analysis","volume":"33","author":"Crowe","year":"2018","journal-title":"Arch Clinical Neuropsychol"},{"issue":"3","key":"10.1016\/j.chest.2022.04.151_bib18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa1610300","article-title":"\u201cZombie\u201d outbreak caused by the synthetic cannabinoid AMB-FUBINACA in New York","volume":"375","author":"Adams","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.chest.2022.04.151_bib7","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1177\/0269881117699616","article-title":"Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep","volume":"31","author":"Piper","year":"2017","journal-title":"J\u00a0Psychopharmacol"},{"issue":"1","key":"10.1016\/j.chest.2022.04.151_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12954-020-00377-0","article-title":"Medical cannabis use in the Australian community following introduction of legal access: the 2018-2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18)","volume":"17","author":"Lintzeris","year":"2020","journal-title":"Harm Reduction J"},{"key":"10.1016\/j.chest.2022.04.151_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fnmol.2020.00125","article-title":"Cannabinoids, endocannabinoids and sleep","volume":"13","author":"Kesner","year":"2020","journal-title":"Front Mol Neurosci"},{"issue":"11","key":"10.1016\/j.chest.2022.04.151_bib10","doi-asserted-by":"crossref","first-page":"zsab149","DOI":"10.1093\/sleep\/zsab149","article-title":"Treating insomnia symptoms with medicinal cannabis: a randomized, cross-over trial of the efficacy of a cannabinoid medicine compared with placebo","volume":"44","author":"Walsh","year":"2021","journal-title":"Sleep"},{"issue":"5","key":"10.1016\/j.chest.2022.04.151_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-034421","article-title":"Cannabidiol (CBD) and \u03949-Tetrahydrocannabinol (THC) for Chronic Insomnia Disorder ('CANSLEEP' Trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial","volume":"10","author":"Suraev","year":"2020","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.chest.2022.04.151_bib12","doi-asserted-by":"crossref","first-page":"zsx184","DOI":"10.1093\/sleep\/zsx184","article-title":"Pharmacotherapy of apnea by cannabimimetic enhancement, the Pace Clinical Trial: effects of dronabinol in obstructive sleep apnea","volume":"41","author":"Carley","year":"2018","journal-title":"Sleep"},{"issue":"4","key":"10.1016\/j.chest.2022.04.151_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11920-017-0775-9","article-title":"Cannabis, cannabinoids, and sleep: a review of the literature","volume":"19","author":"Babson","year":"2017","journal-title":"Curr Psychiatry Rep"},{"issue":"12","key":"10.1016\/j.chest.2022.04.151_bib14","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s40263-020-00773-x","article-title":"Cannabinoids in the treatment of insomnia disorder: a systematic review and meta-analysis","volume":"34","author":"Bhagavan","year":"2020","journal-title":"CNS Drugs"},{"key":"10.1016\/j.chest.2022.04.151_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2020.101339","article-title":"Cannabinoid therapies in the management of sleep disorders: a systematic review of preclinical and clinical studies","volume":"53","author":"Suraev","year":"2020","journal-title":"Sleep Med Rev"},{"issue":"6","key":"10.1016\/j.chest.2022.04.151_bib16","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.smrv.2014.02.005","article-title":"The effects of cannabinoid administration on sleep: a systematic review of human studies","volume":"18","author":"Gates","year":"2014","journal-title":"Sleep Med Rev"},{"issue":"4","key":"10.1016\/j.chest.2022.04.151_bib17","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1037\/pha0000285","article-title":"The use of cannabinoids for sleep: a critical review on clinical trials","volume":"27","author":"Kuhathasan","year":"2019","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.chest.2022.04.151_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejim.2018.01.003","article-title":"The therapeutic effects of cannabis and cannabinoids: an update from the National Academies of Sciences, Engineering and Medicine Report","volume":"49","author":"Abrams","year":"2018","journal-title":"Eur J Intern Med"},{"issue":"24","key":"10.1016\/j.chest.2022.04.151_bib20","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/jama.2015.6358","article-title":"Cannabinoids for medical use: a systematic review and meta-analysis","volume":"313","author":"Whiting","year":"2015","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.chest.2022.04.151_bib21","first-page":"12","article-title":"Novel formulation of Thc and Cbn in a repeat-action tablet improves objective and subjective measurements of sleep","volume":"3","author":"Gannon","year":"2021","journal-title":"Am J Endocannabinoid Medicine"},{"issue":"5","key":"10.1016\/j.chest.2022.04.151_bib22","first-page":"366","article-title":"Cannabinol and sleep: separating fact from fiction","volume":"6","author":"Corroon","year":"2021","journal-title":"Cannabis Cannabinoid Res"},{"issue":"7","key":"10.1016\/j.chest.2022.04.151_bib23","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.biopsych.2015.07.028","article-title":"An introduction to the endogenous cannabinoid system","volume":"79","author":"Lu","year":"2016","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.chest.2022.04.151_bib24","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3390\/ijms19030833","article-title":"Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system","volume":"19","author":"Zou","year":"2018","journal-title":"Int J Molecular Sci"},{"issue":"4","key":"10.1016\/j.chest.2022.04.151_bib25","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid Vr1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"Br J Pharmacol"},{"issue":"9","key":"10.1016\/j.chest.2022.04.151_bib26","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrd1495","article-title":"The endocannabinoid system and its therapeutic exploitation","volume":"3","author":"Marzo","year":"2004","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"10.1016\/j.chest.2022.04.151_bib27","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1476-5381.2010.00790.x","article-title":"Endocannabinoid signalling: has it got rhythm?","volume":"160","author":"Vaughn","year":"2010","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.chest.2022.04.151_bib28","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1210\/jc.2014-3455","article-title":"Circadian rhythm of circulating levels of the endocannabinoid 2-arachidonoylglycerol","volume":"100","author":"Hanlon","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.chest.2022.04.151_bib29","doi-asserted-by":"crossref","first-page":"653","DOI":"10.5665\/sleep.5546","article-title":"Sleep restriction enhances the daily rhythm of circulating levels of endocannabinoid 2-arachidonoylglycerol","volume":"39","author":"Hanlon","year":"2016","journal-title":"Sleep"},{"key":"10.1016\/j.chest.2022.04.151_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2019.104471","article-title":"Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (ECB) N-arachidonoylethanolamine (anandamide)","volume":"111","author":"Hanlon","year":"2020","journal-title":"Psychoneuroendocrinology"},{"issue":"10","key":"10.1016\/j.chest.2022.04.151_bib31","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1097\/00001756-200107200-00018","article-title":"Anandamide-induced sleep is blocked by Sr141716a, a Cb1 receptor antagonist and by U73122, a phospholipase C inhibitor","volume":"12","author":"Murillo-Rodr\u00edguez","year":"2001","journal-title":"Neuroreport"},{"issue":"1","key":"10.1016\/j.chest.2022.04.151_bib32","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0306-4522(02)00820-5","article-title":"Sleep modulates cannabinoid receptor 1 expression in the pons of rats","volume":"117","author":"Martinez-Vargas","year":"2003","journal-title":"Neuroscience"},{"issue":"12A","key":"10.1016\/j.chest.2022.04.151_bib33","doi-asserted-by":"crossref","first-page":"27P","DOI":"10.1016\/j.amjcard.2007.10.011","article-title":"Cannabinoid-1 receptor blockade in cardiometabolic risk reduction: safety, tolerability, and therapeutic potential","volume":"100","author":"Steinberg","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.chest.2022.04.151_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2021.113440","article-title":"Cannabinoids and sleep-wake cycle: the potential role of serotonin","volume":"412","author":"Vaseghi","year":"2021","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.chest.2022.04.151_bib35","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF00437513","article-title":"THC as an hypnotic: an experimental study of three dose levels","volume":"33","author":"Cousens","year":"1973","journal-title":"Psychopharmacologia"},{"issue":"3","key":"10.1016\/j.chest.2022.04.151_bib36","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/BF02245075","article-title":"Acute and residual effects of alcohol and marijuana, alone and in combination, on mood and performance","volume":"115","author":"Chait","year":"1994","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.chest.2022.04.151_bib37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF00634148","article-title":"Marihuana and human physical activity","volume":"50","author":"Babor","year":"1976","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.chest.2022.04.151_bib38","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3389\/fphar.2018.00315","article-title":"No acute effects of cannabidiol on the sleep-wake cycle of healthy subjects: a randomized, double-blind, placebo-controlled, crossover study","volume":"9","author":"Linares","year":"2018","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.chest.2022.04.151_bib39","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.jcp.0000125688.05091.8f","article-title":"Effect of delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults","volume":"24","author":"Nicholson","year":"2004","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.chest.2022.04.151_bib40","doi-asserted-by":"crossref","first-page":"417S","DOI":"10.1002\/j.1552-4604.1981.tb02622.x","article-title":"Hypnotic and antiepileptic effects of cannabidiol","volume":"21","author":"Carlini","year":"1981","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.chest.2022.04.151_bib41","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1213\/ANE.0b013e3181c76f70","article-title":"The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial","volume":"110","author":"Ware","year":"2010","journal-title":"Anesth Analg"},{"key":"10.1016\/j.chest.2022.04.151_bib42","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7812\/TPP\/18-041","article-title":"Cannabidiol in anxiety and sleep: a large case series","volume":"23","author":"Shannon","year":"2019","journal-title":"Perm J"},{"key":"10.1016\/j.chest.2022.04.151_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpsyt.2013.00001","article-title":"Proof of concept trial of dronabinol in obstructive sleep apnea","volume":"4","author":"Prasad","year":"2013","journal-title":"Front Psychiatry"},{"issue":"1","key":"10.1016\/j.chest.2022.04.151_bib44","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5664\/jcsm.3358","article-title":"Impact of dronabinol on quantitative electroencephalogram (qEEG) measures of sleep in obstructive sleep apnea syndrome","volume":"10","author":"Farabi","year":"2014","journal-title":"J\u00a0Clin Sleep Med"},{"issue":"5","key":"10.1016\/j.chest.2022.04.151_bib45","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/jcpt.12179","article-title":"Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson\u2019s disease patients: a case series","volume":"39","author":"Chagas","year":"2014","journal-title":"J Clin Pharm Ther"},{"issue":"7","key":"10.1016\/j.chest.2022.04.151_bib46","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/mds.28577","article-title":"Cannabidiol for rapid eye movement sleep behavior disorder","volume":"36","author":"de Almeida","year":"2021","journal-title":"Mov Disord"},{"key":"10.1016\/j.chest.2022.04.151_bib47","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.sleep.2017.04.019","article-title":"Cannabis for restless legs syndrome: a report of six patients","volume":"36","author":"Megelin","year":"2017","journal-title":"Sleep Med"},{"issue":"1","key":"10.1016\/j.chest.2022.04.151_bib48","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11325-019-01978-1","article-title":"More evidence of cannabis efficacy in restless legs syndrome","volume":"24","author":"Ghorayeb","year":"2020","journal-title":"Sleep Breath"},{"key":"10.1016\/j.chest.2022.04.151_bib90","unstructured":"Australian Clinical Trials. A phase IIb double-blind, randomised placebo-controlled clinical trial to evaluate the efficacy and safety of a botanical cannabidiol (CBD) for sleep disturbances in a healthy population. ACTRN12621000632897. Accessed June 17, 2022. https:\/\/www.australianclinicaltrials.gov.au\/anzctr\/trial\/ACTRN12621000632897"},{"key":"10.1016\/j.chest.2022.04.151_bib91","unstructured":"Australian Clinical Trials. A single-dose, double-blind, placebo-controlled, randomised, crossover study of an oral cannabis-based medicine (ETC120) on sleep, cognition, and next-day function in adults with chronic insomnia disorder. ACTRN12619000714189. Accessed June 17, 2022. https:\/\/www.australianclinicaltrials.gov.au\/anzctr\/trial\/ACTRN12619000714189"},{"key":"10.1016\/j.chest.2022.04.151_bib49","unstructured":"National Institutes of Health Clinical Center. The CANabidiol use for RElief of short term insomnia (CANREST). NCT05253417. ClinicalTrials.gov. National Institutes of Health; 2022. Updated May 18, 2022. http:\/\/clinicaltrials.gov\/ct2\/show\/NCT05253417"},{"key":"10.1016\/j.chest.2022.04.151_bib50","unstructured":"National Institutes of Health Clinical Center. Evaluation of an oral cannabidiol (CBD)-terpene formulation on sleep physiology in participants with insomnia. NCT05233761. ClinicalTrials.gov. National Institutes of Health; 2022. Updated April 14, 2022. http:\/\/clinicaltrials.gov\/ct2\/show\/NCT05233761"},{"key":"10.1016\/j.chest.2022.04.151_bib51","unstructured":"Australian Clinical Trials. Cannabidiol (CBD) treatment for insomnia. ACTRN12620000070932. Accessed June 17, 2022. https:\/\/www.australianclinicaltrials.gov.au\/anzctr\/trial\/ACTRN12620000070932"},{"issue":"1-2","key":"10.1016\/j.chest.2022.04.151_bib52","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.resp.2008.06.021","article-title":"Pharmacology of vagal afferent influences on disordered breathing during sleep","volume":"164","author":"Carley","year":"2008","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.chest.2022.04.151_bib92","unstructured":"Australian Clinical Trials. Proof of concept study on the combined effect of dronabinol and acetazolamide on apnoea hypopnoea index (AHI) in adults with obstructive sleep apnoea. ACTRN12620000916943. Accessed July 18, 2022. https:\/\/www.australianclinicaltrials.gov.au\/anzctr\/trial\/ACTRN12620000916943"},{"issue":"9","key":"10.1016\/j.chest.2022.04.151_bib53","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2174\/1871527318666191021143300","article-title":"Cannabidiol partially blocks the excessive sleepiness in hypocretindeficient rats: preliminary data","volume":"18","author":"Murillo-Rodr\u00edguez","year":"2019","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"2","key":"10.1016\/j.chest.2022.04.151_bib54","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2174\/1871527319666200309115602","article-title":"CSF levels of the endocannabinoid anandamide are reduced in patients with untreated narcolepsy type 1: a pilot study","volume":"19","author":"Romigi","year":"2020","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.chest.2022.04.151_bib55","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejim.2018.01.004","article-title":"Practical considerations in medical cannabis administration and dosing","volume":"49","author":"MacCallum","year":"2018","journal-title":"Eur J Intern Med"},{"issue":"5","key":"10.1016\/j.chest.2022.04.151_bib56","doi-asserted-by":"crossref","first-page":"152","DOI":"10.18773\/austprescr.2020.052","article-title":"Prescribing medicinal cannabis","volume":"43","author":"Arnold","year":"2020","journal-title":"Aust Prescr"},{"key":"10.1016\/j.chest.2022.04.151_bib57","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/3-540-26573-2_23","article-title":"Pharmacokinetics and metabolism of the plant cannabinoids, \u03949-tetrahydrocannabinol, cannabidiol and cannabinol","volume":"168","author":"Huestis","year":"2005","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.chest.2022.04.151_bib58","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neubiorev.2021.01.003","article-title":"Determining the magnitude and duration of acute delta(9)-tetrahydrocannabinol (delta(9)-Thc)-induced driving and cognitive impairment: a systematic and meta-analytic review","volume":"126","author":"McCartney","year":"2021","journal-title":"Neurosci Biobehav Rev"},{"issue":"4","key":"10.1016\/j.chest.2022.04.151_bib59","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","article-title":"Pharmacokinetics and pharmacodynamics of cannabinoids","volume":"42","author":"Grotenhermen","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.chest.2022.04.151_bib60","series-title":"The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research","year":"2017"},{"key":"10.1016\/j.chest.2022.04.151_bib61","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.drugpo.2017.11.008","article-title":"Routes of administration for cannabis use\u2014basic prevalence and related health outcomes: a scoping review and synthesis","volume":"52","author":"Russell","year":"2018","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.chest.2022.04.151_bib63","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejim.2021.05.002","article-title":"\u201cIs medical cannabis safe for my patients?\u201d A practical review of cannabis safety considerations","volume":"89","author":"MacCallum","year":"2021","journal-title":"Eur J Intern Med"},{"issue":"10","key":"10.1016\/j.chest.2022.04.151_bib62","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.3390\/ijms21103495","article-title":"Inhalation toxicology of vaping products and implications for pulmonary health","volume":"21","author":"Traboulsi","year":"2020","journal-title":"Int J Molecular Sci"},{"issue":"6","key":"10.1016\/j.chest.2022.04.151_bib64","doi-asserted-by":"crossref","first-page":"345","DOI":"10.31128\/AJGP-02-21-5845","article-title":"A primer on medicinal cannabis safety and potential adverse effects","volume":"50","author":"Arnold","year":"2021","journal-title":"Aust J Gen Pract"},{"issue":"23","key":"10.1016\/j.chest.2022.04.151_bib65","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1161\/01.CIR.103.23.2805","article-title":"Triggering myocardial infarction by marijuana","volume":"103","author":"Mittleman","year":"2001","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.chest.2022.04.151_bib66","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1192\/bjp.2018.1","article-title":"Cannabis and psychosis: what do we know and what should we do?","volume":"212","author":"Colizzi","year":"2018","journal-title":"Br J Psychiatry"},{"issue":"17","key":"10.1016\/j.chest.2022.04.151_bib67","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1001\/jama.2017.11909","article-title":"Labeling accuracy of cannabidiol extracts sold online","volume":"318","author":"Bonn-Miller","year":"2017","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.chest.2022.04.151_bib68","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1159\/000136944","article-title":"Effects of delta9-tetrahydrocannabinol and cannabinol in man","volume":"13","author":"Karniol","year":"1975","journal-title":"Pharmacology"},{"issue":"2","key":"10.1016\/j.chest.2022.04.151_bib69","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF00434409","article-title":"Intercannabinoid and cannabinoid-ethanol interactions and their effects on human performance","volume":"71","author":"Bird","year":"1980","journal-title":"Psychopharmacology (Berl)"},{"issue":"11","key":"10.1016\/j.chest.2022.04.151_bib70","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.bcp.2010.01.028","article-title":"Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform-selective and potent inhibitors of human Cyp1 enzymes","volume":"79","author":"Yamaori","year":"2010","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"10.1016\/j.chest.2022.04.151_bib71","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1124\/dmd.111.041384","article-title":"Cannabidiol, a major phytocannabinoid, as a potent atypical inhibitor for CYP2D6","volume":"39","author":"Yamaori","year":"2011","journal-title":"Drug Metab Dispos"},{"issue":"8","key":"10.1016\/j.chest.2022.04.151_bib72","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/epi.13060","article-title":"Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy","volume":"56","author":"Geffrey","year":"2015","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.chest.2022.04.151_bib73","first-page":"523","article-title":"Citalopram and cannabidiol: in\u00a0vitro and in\u00a0vivo evidence of pharmacokinetic interactions relevant to the treatment of anxiety disorders in young people","volume":"41","author":"Anderson","year":"2021","journal-title":"J\u00a0Clinical Psychopharmacol"},{"key":"10.1016\/j.chest.2022.04.151_bib74","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ebcr.2017.10.001","article-title":"An interaction between warfarin and cannabidiol, a case report","volume":"9","author":"Grayson","year":"2018","journal-title":"Epilepsy Behav Case Rep"},{"issue":"8","key":"10.1016\/j.chest.2022.04.151_bib75","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/jcph.1412","article-title":"A\u00a0phase 1, open-label, parallel-group, single-dose trial of the pharmacokinetics and safety of cannabidiol (CBD) in subjects with mild to severe hepatic impairment","volume":"59","author":"Taylor","year":"2019","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.chest.2022.04.151_bib76","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.euroneuro.2020.01.006","article-title":"Blunted highs: pharmacodynamic and behavioral models of cannabis tolerance","volume":"36","author":"Ramaekers","year":"2020","journal-title":"Eur Neuropsychopharmacol"},{"issue":"8","key":"10.1016\/j.chest.2022.04.151_bib77","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/cbdv.200790150","article-title":"Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine","volume":"4","author":"Russo","year":"2007","journal-title":"Chem Biodivers"},{"issue":"1","key":"10.1016\/j.chest.2022.04.151_bib78","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/08897077.2015.1023484","article-title":"Cannabis withdrawal and sleep: a systematic review of human studies","volume":"37","author":"Gates","year":"2016","journal-title":"Subst Abus"},{"issue":"7","key":"10.1016\/j.chest.2022.04.151_bib79","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1111\/add.15743","article-title":"Clinical management of cannabis withdrawal","volume":"117","author":"Connor","year":"2022","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.chest.2022.04.151_bib80","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.smrv.2007.12.004","article-title":"Effect of illicit recreational drugs upon sleep: cocaine, ecstasy and marijuana","volume":"12","author":"Schierenbeck","year":"2008","journal-title":"Sleep Med Rev"},{"issue":"5","key":"10.1016\/j.chest.2022.04.151_bib81","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1517\/14740338.2011.575778","article-title":"Abuse potential and psychoactive effects of \u0394-9-tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine","volume":"10","author":"Robson","year":"2011","journal-title":"Exp Opin Drug Saf"},{"issue":"Pt A","key":"10.1016\/j.chest.2022.04.151_bib82","first-page":"10693","article-title":"Abrupt withdrawal of cannabidiol (CBD): a randomized trial","volume":"104","author":"Taylor","year":"2020","journal-title":"Epilepsy Behav"},{"issue":"5","key":"10.1016\/j.chest.2022.04.151_bib83","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0001-4575(99)00110-4","article-title":"The prevalence of alcohol, cannabinoids, benzodiazepines and stimulants amongst injured drivers and their role in driver culpability: part II: the relationship between drug prevalence and drug concentration, and driver culpability","volume":"32","author":"Longo","year":"2000","journal-title":"Accid Anal Prev"},{"issue":"11","key":"10.1016\/j.chest.2022.04.151_bib84","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/jat.3295","article-title":"Cannabis effects on driving longitudinal control with and without alcohol","volume":"36","author":"Hartman","year":"2016","journal-title":"J\u00a0Applied Toxicol"},{"issue":"9","key":"10.1016\/j.chest.2022.04.151_bib85","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1007\/s00213-019-05246-8","article-title":"Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition","volume":"236","author":"Arkell","year":"2019","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.chest.2022.04.151_bib86","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00213-019-05424-8","article-title":"Validating lane drifts as a predictive measure of drug or sleepiness induced driving impairment","volume":"237","author":"Vinckenbosch","year":"2020","journal-title":"Psychopharmacology (Berl)"},{"issue":"21","key":"10.1016\/j.chest.2022.04.151_bib87","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1001\/jama.2020.21218","article-title":"Effect of cannabidiol and delta9-tetrahydrocannabinol on driving performance: a randomized clinical trial","volume":"324","author":"Arkell","year":"2020","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.chest.2022.04.151_bib88","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.drugalcdep.2013.07.031","article-title":"Exercise increases plasma thc concentrations in regular cannabis users","volume":"133","author":"Wong","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.chest.2022.04.151_bib89","doi-asserted-by":"crossref","unstructured":"McCartney D, Suraev AS, Doohan PT, et al. Effects of cannabidiol (CBD) on simulated driving and cognitive performance: a dose-ranging randomised controlled trial [published online ahead of print May 30, 2022]. J Psychopharmacol. https:\/\/doi.org\/10.1177\/02698811221095356","DOI":"10.1177\/02698811221095356"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369222008959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369222008959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T21:03:53Z","timestamp":1715115833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369222008959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":92,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0012369222008959"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2022.04.151","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabinoids, Insomnia, and Other Sleep Disorders","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2022.04.151","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}